CaltechAUTHORS
  A Caltech Library Service

Crystal structure of LIR-2 (ILT4) at 1.8 Å: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18

Willcox, Benjamin E. and Thomas, Leonard M. and Chapman, Tara L. and Heikema, Astrid P. and West, Anthony P., Jr. and Bjorkman, Pamela J. (2002) Crystal structure of LIR-2 (ILT4) at 1.8 Å: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18. BMC Structural Biology, 2 (6). pp. 1-9. ISSN 1472-6807. http://resolver.caltech.edu/CaltechAUTHORS:WILbmcsb02

[img]
Preview
PDF
See Usage Policy.

739Kb

Use this Persistent URL to link to this item: http://resolver.caltech.edu/CaltechAUTHORS:WILbmcsb02

Abstract

Background: Leukocyte Immunoglobulin-like Receptor-1 (LIR-1) and LIR-2 (also known as ILT2 and ILT4 respectively) are highly related cell surface receptors that bind a broad range of class I MHC molecules with low ([Greek mu]M) affinities. Expressed on monocytic cells and macrophages, both molecules transmit inhibitory signals after binding ligands. In addition to binding host class I MHC, the LIR-1 molecule, which is also expressed on lymphoid tissues, binds with a high (nM) affinity to UL18, a class I MHC homolog encoded by Human Cytomegalovirus (HCMV). In comparison, LIR-2 binds UL18 only weakly ([Greek mu]M KD) To understand how HCMV referentially targets the more broadly expressed LIR-1 molecule, we determined the crystal structure of a ligand-binding fragment of LIR-2, and compared this to the existing high-resolution crystal structure of LIR-1. Results: Recombinant LIR-2 (domains 1 and 2) was produced in E. coli and crystallized using streak seeding to optimize the crystal morphology. A data set complete to 1.8 Å was collected at 100 K from a single crystal in the P41212 spacegroup. The structure was solved by molecular replacement, using a search model based on the LIR-1 structure. Conclusions: The overall structure of LIR-2 D1D2 resembles both LIR-1, and Killer Inhibitory Receptors, in that the A strand in each domain forms hydrogen bonds to both [Greek Beta] sheets, and there is a sharp angle between the two immunoglobulin-like domains. However, differences from LIR-1 are observed in each domain, with two key changes apparent in the ligand-binding domain, D1. The region corresponding to the residue 44–57 helix of LIR-1 adopts a topology distinct from that of both LIR-1 and the KIR structures, involving a shortened 310 helix. Secondly, the predicted UL18 binding region of LIR-1 is altered substantially in LIR-2: the 76–84 loop mainchain is displaced 11 Å with respect to LIR-1, and Tyrosine 38 adopts an alternative rotamer conformation. In summary, the structure of LIR-2 has revealed significant differences to LIR-1, including ones that may help to explain the >1000-fold lower affinity of LIR-2 for UL18.


Item Type:Article
Additional Information:© 2002 Willcox et al; licensee BioMed Central Ltd. This article is published in Open Access: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. BEW expressed, purified and produced high quality crystals of LIR-2, carried out data collection and processing, structure solution, refinement and analysis and also wrote the manuscript. LMT carried out the latter stages of refinement and aided structural analyses. TLC produced initial microcrystals of LIR-2. APH carried out molecular cloning of the LIR-2 expression construct. APW provided help during data collection and processing, and critical scientific discussions. PJB conceived of the study, participated in its design and coordination, and provided financial support. Acknowledgements: We thank Drs Z.A. Hamburger, C. A. O'Callaghan and W.L. Martin for assistance with crystallographic software and valuable scientific discussions; D. Cosman for LIR-2 cDNA; S. Rowland-Jones for the kind gift of chinchilla whiskers; and members of the Bjorkman laboratory for critical reading of the manuscript. BEW is supported by a Wellcome Trust Traveling Fellowship (Grant code GR059939MF). Requests for coordinates should be addressed to BEW.
Record Number:CaltechAUTHORS:WILbmcsb02
Persistent URL:http://resolver.caltech.edu/CaltechAUTHORS:WILbmcsb02
Alternative URL:http://dx.doi.org/10.1186/1472-6807-2-6
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:311
Collection:CaltechAUTHORS
Deposited By: Archive Administrator
Deposited On:18 May 2005
Last Modified:26 Dec 2012 08:39

Repository Staff Only: item control page